SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-19-003199
Filing Date
2019-05-20
Accepted
2019-05-20 09:18:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 a2238787z424b5.htm 424B5 321409
2 G538687.JPG g538687.jpg GRAPHIC 15887
3 G897447.JPG g897447.jpg GRAPHIC 20822
4 G267917.JPG g267917.jpg GRAPHIC 24002
5 G75065.JPG g75065.jpg GRAPHIC 93513
6 G516577.JPG g516577.jpg GRAPHIC 102473
  Complete submission text file 0001047469-19-003199.txt   676543
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230674 | Film No.: 19837742
SIC: 2834 Pharmaceutical Preparations